# B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)

> **NCT00302263** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Copenhagen** · enrollment: 22 (—)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Metobes-compound

## Key facts

- **NCT ID:** NCT00302263
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 22 (—)
- **Last updated:** 2006-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302263, "B181 Metobes-III: Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00302263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*